Old Web
English
Sign In
Acemap
>
authorDetail
>
Rolien Bosch
Rolien Bosch
Merck & Co.
Population
Medicine
Dried blood spot
Anesthesia
Pharmacokinetics
4
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Making Better Dose Decisions: Using Exposure‐Response Modeling to Integrate Efficacy Outcome of Two Phase 2b Clinical Trials of Ubrogepant for Migraine Treatment
2019
Clinical and Translational Science
Chi-Chung Li
Tiffini Voss
Ken Kowalski
Bei Yang
Huub-Jan Kleijn
Christopher Jones
Rolien Bosch
David Michelson
Matthew DeAngelis
Yang Xu
Iris Xie
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (2)
Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling
2018
The Journal of Clinical Pharmacology
Chi‐Chung Li
Marissa Dockendorf
Ken Kowalski
Bei Yang
Yang Xu
Iris Xie
Huub-Jan Kleijn
Rolien Bosch
Christopher Jones
Bob Thornton
Eugene E. Marcantonio
Tiffini Voss
Kevin P. Bateman
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (22)
A PK-PD model-based assessment of sugammadex effects on coagulation parameters.
2016
European Journal of Pharmaceutical Sciences
Rolien Bosch
Marie-José van Lierop
Pieter-Jan de Kam
Kruithof Ac
Jacobus Burggraaf
Rik de Greef
Sandra A.G. Visser
Amy O. Johnson-Levonas
Huub-Jan Kleijn
Show All
Source
Cite
Save
Citations (3)
Population Modeling Is a Critical Element of Bridging Pharmacokinetic Data From Dried Blood Spot and Plasma Across Clinical Programs
2014
Marissa Dockendorf
Ken Kowalski
B. Yang
L. Ma
Huub-Jan Kleijn
Rolien Bosch
M. Forman
G. Marcantonio
Tiffini Voss
D. Jaworowicz
J. Passarell
Kevin P. Bateman
Julie A. Stone
Prajakti A. Kothare
Show All
Source
Cite
Save
Citations (0)
1